The Global Fund paid for a malaria mass drug admininstration trial in a *low* transmission setting in Myanmar *six* years ago. Results are out this week.
"malaria elimination programmes should consider using MDA ... in foci of higher transmission"
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30997-X/fulltext
What do you think?
Jamie
